Industry perceptions of barriers to commercialization of regenerative medicine products in the UK

Aims Regenerative medicine is an emerging field with the potential to provide widespread improvement in healthcare and patient well-being via the delivery of therapies which can restore, regenerate or repair damaged tissue. As an industry, it could significantly contribute to economic growth if products are successfully commercialized. However, to date, relatively few products have reached the market due to a variety of barriers, including a lack of funding and regulatory hurdles. The present study analyzes industry perceptions of the barriers to commercialization which currently impede the success of the regenerative medicine industry in the UK. Materials & Methods The analysis is based on twenty interviews with leading industrialists in the field. Results The study revealed that scientific research on regenerative medicine is thriving in the UK. Unfortunately, lack of access to capital, regulatory hurdles, lack of clinical evidence leading to problems with reimbursement, as well as the culture of the NHS do not provide a good environment for the commercialization of RM products. Conclusions Policy interventions, including increased translational government funding, a change in NHS and NICE organisation and policies as well regulatory clarity would likely improve the general outcomes for the regenerative medicine industry in the UK

Developing a National Design Scoreboard

Recognising the growing importance of design, this paper reports on the development of an approach to measuring design at a national level. A series of measures is proposed, that are based around a simplified model of design as a system at a national level. This model was developed though insights from literature and a workshop with government, industry and design sector representatives. Detailed data on design in the UK is presented to highlight the difficulties in collecting reliable and robust data. Evidence is compared with four countries (Spain, Canada, Korea and Sweden). This comparison highlights the inherent difficulties in comparing performance and a revised set of measures is proposed. Finally, an approach to capturing design spend at a firm level is proposed, based on insights from literature and case studies. Keywords: National Design System, Design Performance</p

Vision and characteristics of multi KETs pilot lines: Intermediary report. Version 5.0

This report represents an intermediary deliverable of the mKETs-Pilot line project. Its aim is to create a level playing field for discussion on policy recommendations for multi-KETs Pilot production activities by introducing current thinking on relevant key-concepts. In the course of the project, this report will further evolve; key-concepts will be further defined, using the outcomes of the workshops, additional insights through expert interviews and desk research, and Phase II Demonstrator case studies. Elements of the report should subsequently be regarded as preliminary hypothesis, to be refined and finalised in later stages of the project